James C. Powers
Mr. Powers is an independent business strategy consultant focusing on services for the pharmaceutical and medical device industries. He is a member of several boards in the pharmaceutical services sector and an advisor to Tall Oaks Capital, the Coulter Translational Research Partnership in Biomedical Engineering at the University of Virginia and the University of Virginia’s Nursing Ventures initiative.
In 2006, he retired from PRA International (NASDAQ:PRAI), a global clinical research organization serving pharmaceutical, biotechnology and medical device companies, after 18 years in executive management. He oversaw PRA’s growth from a niche data management services provider to a full service clinical trials management organization, and expanded its operations and customer base from US-centric to international. Mr. Powers launched PRA’s oncology therapeutic focus, a market in which PRA continues to be a leader, and he was instrumental in strategic planning and eight acquisitions. During his tenure, the company grew from less than $1 million to more than $450 million in annual sales and a global work force of more than 3,000 employees. Before joining PRA, Mr. Powers was responsible for identifying and managing medical technology startup businesses for University Technology Corporation. Mr. Powers received a BS in administration and management science from Carnegie-Mellon University.
Mr. Powers is an independent business strategy consultant focusing on services for the pharmaceutical and medical device industries. He is a member of several boards in the pharmaceutical services sector and an advisor to Tall Oaks Capital, the Coulter Translational Research Partnership in Biomedical Engineering at the University of Virginia and the University of Virginia’s Nursing Ventures initiative.
In 2006, he retired from PRA International (NASDAQ:PRAI), a global clinical research organization serving pharmaceutical, biotechnology and medical device companies, after 18 years in executive management. He oversaw PRA’s growth from a niche data management services provider to a full service clinical trials management organization, and expanded its operations and customer base from US-centric to international. Mr. Powers launched PRA’s oncology therapeutic focus, a market in which PRA continues to be a leader, and he was instrumental in strategic planning and eight acquisitions. During his tenure, the company grew from less than $1 million to more than $450 million in annual sales and a global work force of more than 3,000 employees. Before joining PRA, Mr. Powers was responsible for identifying and managing medical technology startup businesses for University Technology Corporation. Mr. Powers received a BS in administration and management science from Carnegie-Mellon University.
